Batinic-Haberle Lab

Publications

PUBLICATIONS  2009-2013
Out of total 160 publications

  1. Mn porphyrin regulation of aerobic glycolysis: Implications on the activation of diabetogenic Immune Cells. Delmastro-Greenwood M. M, Votyakova T., Goetzman, E., Marre, M. L., Previte, D. M., Tovmasyan, A., Batinic-Haberle, I., Trucco, M. M., Piganelli, J. D. Antioxid Redox Signal, 2013, accepted. doi:10.1089/ars.2012.5167.
  2. Mechanistic insights on glycidamide-induced toxicity and genotoxic effects in human mammary cells, Bandarra, S., Fernandes, A. S., Magro, I., Geuerreiro, P. S., Pingarilho, M., Churchwell, M. I., Monteiro Gil, O. M., Batinic-Haberle, I., Goncalves, S., Rueff, J., Miranda, J. P., Marques, M. M., Belad, F., A., Castro, M., Gaspar, J. F., Oliveira, N. G., Mutagenesis, 2013, in press.
  3. The complex mechanistic aspects of redox-active compounds, commonly regarded as SOD mimics, Ines Batinic-Haberle, Artak Tovmasyan and Ivan Spasojevic, BioInorganic Reaction Mechanisms, invited paper 2013, submitted.
  4. Differential coordination demands in Fe vs Mn water-soluble cationic metalloporphyrins translates into remarkably different aqueous redox chemistry and biology, Artak Tovmasyan, A., Weitner, T., Sheng, H., Lu, M., Rajic, Z., Warner, D. S., Spasojevic, I., Reboucas, J. S., Benov, L., Batinic-Haberle, I.,  Inorg Chem, 2013, 5677-5691.PubMEd 23646875, Publ.ID ic3012519, NIHMSID 476823
  5. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+ Weitner, T., Kos, I., Sheng, H., Tovmasyan, A., Reboucas, J. S., Fan, P., Warner, D. S. Vujaskovic, Z., Batinic-Haberle, I., Spasojevic, I. Free Radic Biol Med, 2013 Jan 15;58C:73-80,dx.doi.org/101016/j.freeradbiomed.2013.01.006. NIHMSID #435982.
  6. Intracellular targeting and pharmacological activity of the superoxide dismutase mimics MnTE-2-PyP5+ and MnTnHex-2-PyP5+ regulated by their porphyrin ring substituents. Aitken, J. B., Giles, N. M., Lai, B., Vogt, S., Reboucas, J. S., Batinic-Haberle, I., Lay, P. A., Giles, G. I., Inorg Chem 2013, 52, 4121-3.
  7. Radiation induces aerobic glycolysis through reactive oxygen species, Zhong, J., Rajaram, N., Brizel, D. M., Frees, A. E.,  Ramanujam, N., Batinic-Haberle, I., Dewhirst, M. W.,  Radiotherapy and Oncology 2013, Mar;106(3):390-6.
  8. Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death, Evans, M. K., Tovmasyan, A., Batinic-Haberle, Devi, G. R., Free Radic Biol  Med, 2013, in revision.
  9. Copper chelator ATN-24 induces peroxynitrite dependent cell death in hematological malignancies, Lee, K., Briehl, M. M., Mazar, A. P., Batinic-Haberle, I., Reboucas, J. S., Glinsmann-Gibson, B., Rimsza, L. M., Tome M. E., Free Radic Biol Med in press, 2013. doi:pii: S0891-5849(13)00056-7. 10.1016/j.freeradbiomed.2013.02.003.
  10. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia Jumbo-Lucioni, P., Hopson, M. L., Heather Bishop, H., Weitner, T., Tovmasyan, A., Spasojevic, I., Batinic-Haberle, I., Liang, Y., Jones, D. P., Fridovich-Keil, J. L., Antioxid. Redox Signal 2013, published online, invited manuscript for Forum Issue on “SOD therapeutics”. doi:10.1089/ars.2012.5122.
  11. SOD therapeutics: Latest insights into their structure-activity relationships and their impact on cellular redox-based pathways, Batinic-Haberle I., Tovmasyan A., Roberts, E., Vujaskovic Z., Leong, K. W., Spasojevic, I. Antioxid. Redox Signal 2013, invited manuscript for Forum Issue on “SOD therapeutics”. doi:10.1089/ars.2012.5147
  12. The administration of renoprotective agents extends warm ischemia in a rat model, Cohen, J., Dorai, T.,  Ding, C., Batinic-Haberle, I., Grasso, M., J Endourology, 2013 Mar;27(3):343-8, doi:10.1089/end.2012.0194.
  13. Peroxynitrite formation in nitric oxide-exposed submitochondrial particles: Detection, oxidative damage and catalytic removal by Mn porphyrins, Valez, V., Cassina, A., Batinic-Haberle, I., Ferrer-Sueta, G., Radi, R., Arch Biochem Biophys, 2013, 529, 45-54. 
  14. Thermal Stability of the Prototypical Mn porphyrin-based Superoxide Dismutase Mimic and Potent Oxidative-Stress Redox Modulator Mn(III) meso-Tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP5+, Pinto, V. H. A., Dayse CarvalhoDa-Silva, D., Santos, J. L. M. S., Weiner, T., Da Fonseca, M. G., Maria Irene Yoshida, M. I., Idemori, Y., M., Batinić-Haberle, I., S. Rebouças, J. S. J. Pharm. Biomed. Anal. 2013, 25;73:29-34, dx.doi.org/10.1016/j.jpba.2012.03.033. PMID:2503130
  15. Pro- vs anti-oxidative effects of Mn porphyrin-based SOD mimic in diabetic rat is controlled by dosing regimen. Ali, D. K., Oriowwo, M., Tovmasyan, A., Batinic-Haberle, I., Benov, L. Redox Biology, in press, 2013.
  16. Effect of molecular characteristics on cellular uptake, subcellular localization and phototoxicity of Zn(II) N-alkylpyridylporphyrins, Ezzeddine R., Al-Banaw, A., Tovmasyan, A., Craik, J. D., Batinic-Haberle, I., Benov, L.T., J. Biol Chem, submitted, 2013.
  17. Superoxide dismutase mimics, Spasojevic I, Ines Batinic-Haberle I. in Principles of Free Radical Biomedicine, Kostas Pantopoulos and Hyman Schipper Eds., Nova Science Publishers, Inc, Hauppauge New York, 2011, in press, 2012, volume 2, Chapter 6, 101-128, invited Book Chapter.
  18. Manganese porphyrin acts as a pro-oxidant to glutathionylate the p65 subunit of NF-κB and potentiate glucocorticoid-induced apoptosis in lymphoma cells, Jaramillo, M. C., Briehl, M. M., Crapo, J. D., Batinic Haberle, I., Tome, M. E. Free Radic Biol Med  2012, 52, 1272-1284, NIHMS# 364684, PMCID, PMC3331723
  19. Protein damage by photoactivated Zn(II) N-alkylpyridylporphyrins Benov L., Craik J., Batinic-Haberle I., Amino Acids, 2012, 42:117-28 in press, PMID: 20559672; doi: 10.1007/s00726-010-0640-1. Special Issue co-edited by Ines Batinic-Haberle.
  20. ErbB1/2 Tyrosine Kinase Inhibitor Mediates Oxidative Stress-Induced Apoptosis in Inflammatory Breast Cancer Cells, Katherine M. Aird, M. K., Batinic-Haberle, I., Lyerly, H. K., Dewhirst, M. W., Devi, G. R., Breast Cancer Research and Treatment 2012 132:109-19.
  21. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Batinic-Haberle I., Spasojevic I., Tse, HM, Tovmasyan A., St. Clair D. K., Vujaskovic, Z., Dewhirst M. W., Piganelli J. D. Amino Acids, 2012, 42:95-113, invited review.
  22. Mn porphyrins as novel molecular MRI cancer agents, Mouraviev, V., Venkatraman T., Kumura, M., Tsivian, M., Mouravieva V., Tovmasyan, A., Polascik T. J., Amrheim, T., Lascola, C., J Endourology, 2012 Nov;26(11):1420-4, DOI: doi:10.1089/end.2012.0171.
  23. Acid-base and Electrochemical Properties of Manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: Voltammetric and Chronocoulometric Study of Protolytic and Redox Equilibria, Weitner, T., Kos, I., Mandić, Z., Batinić-Haberle, I., Biruš, M. Dalton Trans, 2013, doi: 10.1039/c3dt50767j.
  24. Design, mechanism of action,  bioavailibility and therapeutic effects of Mn porphyrin-based redox modulators, Tovmasyan, A., Sheng H., Weitner, T., Arulpragasam, A., Lu, M.,  Warner, D. S., Vujaskovic Z., Spasojevic, I.,  Batinic-Haberle, I. Medical Principles and Practice, in press, 2012 DOI: 10.1159/000341715. PubMed # 23075911 NIHMSID # 443034
  25. Protein modification by amphiphilic Zn(II) N-alkylpyridylporphyrin photosensitizers, Craik, J. D., Ghazal, M., Batinic-Haberle, I., Benov, L. T. Free Radic Biol Med  2013, submitted.
  26. XIAP inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer Cells, Allensworth, J. A., Aird, K. A., Aldrich, A. J., Batinic-Haberle, I., Devi, G. R., Mol. Cancer Ther. 2012, 11, 1518-27.doi: 10.1158/1535-7163.MCT-11-0787.
  27. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin combines superb potency and lipophilicity with low toxicity, Rajic, Z., Tovmasyan, A., Spasojevic, I., Sheng, H., Lu, M., Gralla, E. B., Warner, D. S., Benov, L., Batinic-Haberle, I. Free Radic Biol Med, 2012, 52, 1828-1834, doi:10.1016/j.freeradbiomed.2012.02.006, PMID: 22336516.
  28. Motor deficits are triggered by reperfusion-reoxygenation injury as diagnosed by MRI and by a mechanism involving oxidants, Drobyshevsky A., Luo K., Derrick, M., Yu, L., Prasad, P. V., Vasquez-Vivar, J., Batinic-Haberle, I., Tan., S., J. Neurosci  2012, 32:5500-9. PUBMED 22514312.
  29. Manganese superoxide dismutase, MnSOD and its mimics, Miriyala, S., Tovmasyan, A., Spasojevic, I., Salvemini, D., Vujaskovic, Z., St. Clair, D. K., Batinic-Haberle, I., Biochim. Biophys Acta, invited review, 2012, 52, 1822:794-814, PMID: 22198225
  30. Manganese superoxide dismutase is a mitochondrial fidelity protein that protects Polg against UV-induced inactivation, Bakthavatchalu, V., Dey, S., Xu, Y., Noel, T., Jungsuwadee, P., Holley, A. K., Dhar, S. K.,  Batinic-Haberle, I.,St. Clair, D. K., Oncogene, 2012, 31:2129-39.
  31. Detailed Mechanism of the Autoxidation of N-hydroxyurea Catalyzed by an SOD mimic Mn(III) porphyrin: Formation of the Nitrosylated Mn(II) porphyrin as an Intermediate, Kalmár, J., Biri, B., Lente, G., Bányai, I., Budimir, A. Biruš, M., Batinić-Haberle, I., Fábián, I.,  Dalton Trans 2012, 11875-11884, PMID: 22911446
  32. SOD Enzymes and their Mimics in Cancer: Pro vs Anti-Oxidative Mode of Action. Part I. Batinic-Haberle, I., Anticancer Agents Med Chem. 2011, 11, 172-174. Special Issue edited by Ines Batinic-Haberle.
  33. Author Response on SOD mimics, Rosenthal RA, Doctrow SR, Callaway WB, Letter to Editor and Batinic-Haberle I, Reboucas JS, Spasojevic I, Antioxid Redox Signal 2011, 14, 1174-6.
  34. Vitamin C i maligne bolesti, Rajic, Z., Perkovic, I., Batinic-Haber;le I., Farmaceutski glasnik 2011, 67, 303-310.
  35. A combination of two antioxidants (and SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon, Batinic-Haberle, I., Rajic, Z., Benov, L., Anticancer Agents Med. Chem. 2011, 11, 329-340. Special Issue edited by Ines Batinic-Haberle.
  36. Amelioration of renal ischemia-reperfusion injury with a novel protective cocktail, Dorai, T., Fishman, A. I.., Ding, C., Batinic-Haberle, I., Goldfarb, D, S., Grasso, M., J Urology, 2011, 186:2448-54, doi: 10.1016/juro.2011.08.010.
  37. Manganese Porphyrin Reduces Retinal Injury Induced by Ocular Hypertension, Dogan, S. Unal, M., Ozturk, N., Yargicoglu, P., Cort, A., Spasojevic, I., Batinic-Haberle, I., Aslan, M., Experimental Eye Research, in press 2011; 93:387-96. doi:10.1016/j.exer.2011.05.008.
  38. Methoxy-derivatization of alkyl chains increases the efficacy of cationic Mn porhyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins, Tovmasyan, A., Rajic, Z., Spasojevic, I., Reboucas J.S., Chen, X., Sheng, H., Warner, S. D., Benov, L., Batinic-Haberle, I., Dalton Trans. 2011, 40, 4111-4121, DOI:10.1039/C0DT01321H. PubMed # 21384047, NIHMSID #452497
  39. The potential of Zn(II) N-alkylpyridylporphyrins for anticancer therapy Benov, L., Craik, J., Batinic-Haberle, I., Anticancer Agents in Medicinal Chemistry, 2011, 11, 233-241. Special Issue edited by Ines Batinic-Haberle.
  40. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized  as SOD mimics, Batinic-Haberle, I., Rajic, Z., Tovmasyan, A., Reboucas, J. S., Ye, X., Leong, K. W., Dewhirst, M. W. Vujaskovic, Z., Benov, L., Spasojevic, I. Free Radic Biol Med, invited review, 2011, 51, 1035-1053.
  41. Chemistry, biology and medical effects of water-soluble porphyrins, Batinic-Haberle, I., Reboucas J. S., Benov, L., Spasojevic, I., in Handbook of Porphyrin Science, Kadish KM, Smith KM, Guillard R, EDs.; vol 11, World Scientific, 2011, invited Book Chapter, 291-393.
  42. Neuroprotective Efficacy From Parenteral Administration Of A Redox-Modulating lipophilic MnPorphyrin, MnTHex-2-PyP5+ , Sheng, H., Spasojevic, I., Tse, H. M., Jung, J. Y., Zhang, Z., Piganelli, J., Batinic-Haberle I., Warner, D. S., J Pharmacol. Exp. Ther. 2011, 338, 906-916.
  43. 2-hydroxyglutarate production, but not dominant negative activity, is shared by a panel of glioma-derived IDH1 R132 and IDH2 R172 mutants Jin, G., Reitman, Z.J., Spasojevic, I., Batinic-Haberle, I., Yang, I., Schmidt-Kittler, O., Bigner, D., Yan, H. PLOS One 2011, 6, e16812.
  44. NADPH oxidase inhibition attenuates total body-irradiation-induced hematopoietic genomic instability, Pazhanisamy S. K., Li, H., Batinic-Haberle , I., Zhou, D., Mutagenesis, 2011, 26, 431-435.
  45. Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin (MnTE-2-PyP5+) mitigates total body irradiation-induced long-term bone marrow suppression, Li, H., Wang, Y., Senthil K. Pazhanisamy, S. K., Shao, L., Batinic-Haberle, I., Meng, A., Zhou, D., Free Radic Biol Med, 2011, 51: 30-37, 10.1016/j.freeradbiomed.2011.04.016.
  46. Cellular redox modulator, Mn(III)  meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors, Keir, S. T., Batinic-Haberle, I., and Darell D. Bigner, D. D. Anticancer Drugs in Medicinal Chemistry, 2011, 11, 202-212. Special Issue edited by Ines Batinic-Haberle.
  47. Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate, Ye, X., Fels, D., Tovmasyan, A., Aird, K., DeDeugd C., Allensworth, J. L., Kos, I., Park, W., Spasojevic, I., Devi., G., Dewhirst, M. W., Leong, K. W., Batinic-Haberle I., Free Radic Res. 2011, 45(11-12):1289-306.
  48. Bioavailability of metalloporphyrin-based SOD mimics is greatly influenced by a single charge residing on a Mn site, Spasojevic I., Kos I., Benov, L. T.,  Rajic Z., Fels, D., Dedeugd, D., Ye, X., Vujaskovic, Z., Reboucas, J. S., Leong, K., Dewhirst, D. W. Batinic-Haberle, I., Free Radic Res 2011, 45, 188-200, DOI:10.3109/10715762.2010.522575.
  49. NADPH oxidase-mediated ROS production activates HIF-1 via the ERK paythway after hyperthermia treatment, Moon, E. J., Sonveaux, P., Porporato, P. E., Danhier, P., Gallez, N., Batinic-Haberle, I., Nien, Y-C., Schroeder, T., Dewhirst, M. W., Proc Natl Acad Sci, 2010, 107, 20477-20482.
  50. Proteomic Analysis of Radiation-Induced Changes in Rat Lung: Modulation by the Superoxide Dismutase Mimetic MnTE-2-PyP(5+), Yakovlev VA, Rabender CS, Sankala H, Gauter-Fleckenstein B, Fleckenstein K, Batinic-Haberle I, Jackson I, Vujaskovic Z, Anscher MS, Mikkelsen RB, Graves PR Int J Radiat Oncol Biol Phys. 2010, 78, 547-554. Jun 26. [Epub ahead of print].
  51. Thermodynamics and electrochemistry of manganese tetra(ortho-n-butylpyridyl)porphyrin in aqueous solut1ions, Budimir A, Smuc T, Weitner T, Batinic-Haberle I, Birus M, J Coord Chem, 2010, 63, 2750-2765.
  52. Superoxide dismutase mimics: chemistry, pharmacology and therapeutic potential, Batinic-Haberle I., Reboucas, J. S., Spasojevic, I. Antiox Redox Signaling 2010, 13:877-918, published online January 2010 (doi: 10.1089/ars.2009.2876), invited comprehensive review.
  53. Acid-base and Electrochemical Properties of Manganese meso(ortho- and meta-ethylpyridyl)porphyrins: Potentiometric, Spectrophotometric and Spectroelectrochemical Study of Protolytic and Redox Equilibria, Tin Weitner, T., Budimir, I., Batinić-Haberle, I., Biruš, M. Dalton Trans 2010, 39, 11568–11576.
  54. Water exchange rate of water-soluble Manganese (III) porphyrins of therapeutic potential, Budimir, A., Kalmar J., Farkas E, Banyai I, Batinic-Haberle, I, Birus, M., Dalton Trans 2010, 4405-4410.
  55. Protective role of ortho-substituted Mn(III) N-alkylpyridylporphytrins against the oxidative injury induced by tert-butylhydroperoxide. Fernandes AS, Gaspar J, Cabral MF, Rueff J, Castro M, Batinic-Haberle I, Costa J, Oliveira NG. Free Radic Res. 2010, 44:430-40 doi: 10.3109/10715760903555844.
  56. Early and late administration of antioxidant mimic MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage, Gauter-Fleckenstein, B., Fleckestein, K., Owzar, K., Jiang, C., Reboucas, J.S., Batinic-Haberle, I., Vujaskovic, Z., Free Radic. Biol. Med. 2010, 48, 1034-1043.
  57. Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance, Doyle, T., Bryant, L., Batinic-Haberle, I., Little, J., Cuzzocrea, S., Masini, E., Spasojevic, I., Salvemini, D., Neuroscience, 2009, 164:702-710.
  58. High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based SOD mimics compensates for their lower antioxidant potency and makes them equally effective as ortho analogues in protecting SOD-deficient E. coli Kos, I., Benov, L.,  Spasojević, I., Rebouças, J. S., Batinic-Haberle, I., J. Med. Chem. 2009, 52, 7862-7872.
  59. Lipophilicity of porphyrin-based antioxidants: Comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins, Kos, I., Reboucas, J. S., DeFreitas-Silva, G., Vujaskovic, Z., Dewhirst, M. W., Spasojevic, I., Batinic-Haberle, I., Free Radic. Biol. Med. 2009, clear 47: 72–78.
  60. IDH1 and IDH2 gene mutations play a fundamental role in astrocytoma and oligodendroglioma development, Yan, H.; Parsons, D. W.; Jin G., McLendon, R. Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., Friedman, H., Friedman, A., Reardon, D., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., Bigner, D. D., New Engl. J. Med. 2009; 360, 765-773.
  61. The effect of lipophilicity of Mn (III) ortho N-alkylpyridyl- and diortho N, N’-imidazolylporphyrins in two in-vitro models of oxygen and glucose deprivation -induced neuronal death, Wise-Faberowski, L., Warner, D. S., Spasojevic, I., Batinic-Haberle, I., Free Radic. Res. 2009, 43:329-339.
  62. Determination of residual manganese in Mn-porphyrin-based SOD and peroxynitrite reductase mimics, Reboucas, J. S., Kos, I., Batinic-Haberle, I., J. Pharm. Biomed. Analysis, 2009, 1088-1091.
  63. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP5+, via suppression of oxidative stress in a mouse model of breast tumor, Rabbani, Z. N., Spasojevic, I., Vasquez-Vivar, J., Haberle, S., Salvemini, D., Dewhirst, M. W., Vujaskovic, Z., Batinic-Haberle,, I., Free Radic. Biol. Med. 2009, 47: 992–1004.
  64. Radioprotective effects of manganese-containing superoxide dismutase mimics on ataxia telangiectasia cells, Pollard, J., Reboucas, J. S., Durazo, A., Kos, I., Fike, F., Panni, M., Gralla, E. B., Valentine, J. S., Batinic-Haberle, I., Gatti, R. A., Free Radic. Biol. Med. 2009, 47: 250-260.
  65. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking morphine tolerance through peroxynitrite-mediated pathways, Batinic-Haberle, I., Ndengele, M. M., Cuzzocrea, S., Reboucas, J. S., Masini, E., Spasojevic, I., Salvemini, D., Free Radic. Biol. Med. 2009, 46, 212-219.
  66. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: Comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two different models of oxidative stress injuries, SOD-specific E. coli model and carrageenan-induced pleurisy” by Batinić-Haberle, I., Cuzzocrea, S., Rebouças, J. S., Ferrer-Sueta, G., Emanuela Mazzon, E.,  Di Paola, R., Radi, R.,  Spasojević, I., Benov, L., Salvemini, D. Free Radic. Biol. Med. 2009, clear46, 192-201.
  67. Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the rat, Sheng, H., Sakai, H., Yang, W., Fukuda, S., Salahi, M., Day, B. J., Huang, J., Paschen, W., Batinic-Haberle, I., Crapo, J. D., Pearlstein, R. D., Warner, D. S. Free Radic. Biol. Med 2009, 47, 917-921, doi.10.1016/j.freeradbiomed.2009.05.039.
  68. Effect of potent redox-modulating manganese porphyrin, MnTM-2-PyP on the Na+/H+ exchangers NHE-1 and NHE-3 in the diabetic, Khan, I., Batinic-Haberle, I., Benov, L., Redox Report 2009, 6, 236-242.